Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

18.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cells.

Frontiers in immunology·2026
Same author

The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.

Nature cancer·2026
Same author

Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non-Small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Delayed gastric emptying after robot-assisted pancreatoduodenectomy: the Transatlantic Robot Pancreas Consortium (TROPANC).

Surgical endoscopy·2026
Same author

Impact of Surgical Approach on Post-Pancreatoduodenectomy Bleeding: A Multi-Center Analysis.

Annals of surgery·2026
Same author

A Retrospective Examination of Neoadjuvant Chemotherapy for Metachronous Colorectal Peritoneal Metastases Prior to CRS/HIPEC.

Annals of surgical oncology·2026
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.7K

B-cell-directed Immunotherapy for Solid Tumors.

Renee R Anderko1, Adam Tcharni2, Amer H Zureikat3

  • 1Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Hillman Cancer Center, University of Pittsburgh, 1.48 Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.

Surgical Oncology Clinics of North America
|March 28, 2026
PubMed
Summary
This summary is machine-generated.

B-cell immunotherapy shows promise for solid tumors, overcoming challenges with new strategies. Advanced technologies like AI and spatial transcriptomics will enhance B-cell therapies for better cancer treatment.

Keywords:
B cellsCAR-B cell therapyCD40 agonistsEngineered B cellsImmunotherapySTING/LIGHTTertiary lymphoid structuresTumor-infiltrating B cell

More Related Videos

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.4K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Related Experiment Videos

Last Updated: Mar 30, 2026

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.7K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.4K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • B-cell immunotherapy offers potential for solid tumors, unlike T-cell therapies limited by tumor microenvironment barriers.
  • Desmoplastic stroma and low immunogenicity impede current T-cell treatments in solid tumors.

Purpose of the Study:

  • To explore novel B-cell-directed immunotherapy strategies for solid tumors.
  • To address challenges limiting B-cell therapy efficacy, including phenotypic plasticity and functional heterogeneity.

Main Methods:

  • Reviewing ongoing clinical trials for B-cell immunotherapy in solid tumors.
  • Investigating strategies such as B-cell exhaustion reversal, tertiary lymphoid structure induction, and B-cell receptor engineering.
  • Utilizing emerging technologies like AI-driven epitope prediction and spatial transcriptomics.

Main Results:

  • Diverse B-cell-directed strategies are under investigation, including B-cell rejuvenation and enhanced tumor specificity.
  • New technologies show potential to overcome B-cell heterogeneity and plasticity challenges.
  • Spatial transcriptomics aids in understanding tertiary lymphoid structures.

Conclusions:

  • B-cell immunotherapy presents a promising avenue for solid tumor treatment.
  • Overcoming B-cell plasticity and heterogeneity is key to therapeutic success.
  • Advanced technologies are crucial for unlocking the full potential of B-cell-based cancer therapies.